Sequent Scientific Limited Stock Current Valuation
| SEQUENT Stock | 203.32 4.05 2.03% |
Valuation analysis of Sequent Scientific helps investors to measure Sequent Scientific's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Sequent Scientific's Change In Cash is comparatively stable compared to the past year. Other Non Cash Items is likely to gain to about 301.1 M in 2024, whereas Cash And Equivalents is likely to drop slightly above 1.2 M in 2024. Fundamental drivers impacting Sequent Scientific's valuation include:
Price Book 7.3274 | Enterprise Value 53.7 B | Enterprise Value Ebitda 37.4552 | Price Sales 3.5611 | Forward PE 33.3333 |
Overvalued
Today
Please note that Sequent Scientific's price fluctuation is very steady at this time. Calculation of the real value of Sequent Scientific is based on 3 months time horizon. Increasing Sequent Scientific's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Sequent Scientific's intrinsic value may or may not be the same as its current market price of 203.32, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 203.32 | Real 168.91 | Hype 203.61 | Naive 182.89 |
The intrinsic value of Sequent Scientific's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sequent Scientific's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sequent Scientific Limited helps investors to forecast how Sequent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sequent Scientific more accurately as focusing exclusively on Sequent Scientific's fundamentals will not take into account other important factors: Sequent Scientific Limited Company Current Valuation Analysis
Sequent Scientific's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Sequent Scientific Current Valuation | 53.69 B |
Most of Sequent Scientific's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sequent Scientific Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Sequent Scientific Limited has a Current Valuation of 53.69 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all India stocks is notably lower than that of the firm.
Sequent Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sequent Scientific's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sequent Scientific could also be used in its relative valuation, which is a method of valuing Sequent Scientific by comparing valuation metrics of similar companies.Sequent Scientific is currently under evaluation in current valuation category among its peers.
Sequent Fundamentals
| Return On Equity | -0.0405 | ||||
| Return On Asset | 0.0031 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 53.69 B | ||||
| Shares Outstanding | 249.35 M | ||||
| Shares Owned By Insiders | 52.98 % | ||||
| Shares Owned By Institutions | 13.16 % | ||||
| Price To Book | 7.33 X | ||||
| Price To Sales | 3.56 X | ||||
| Revenue | 13.7 B | ||||
| Gross Profit | 5.63 B | ||||
| EBITDA | 549.8 M | ||||
| Net Income | (358.69 M) | ||||
| Total Debt | 4.88 B | ||||
| Book Value Per Share | 26.37 X | ||||
| Cash Flow From Operations | 305.95 M | ||||
| Earnings Per Share | 0.66 X | ||||
| Target Price | 133.5 | ||||
| Number Of Employees | 1.2 K | ||||
| Beta | 0.82 | ||||
| Market Capitalization | 48.54 B | ||||
| Total Asset | 15.4 B | ||||
| Retained Earnings | 1.2 B | ||||
| Working Capital | 1.96 B | ||||
| Net Asset | 15.4 B |
About Sequent Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sequent Scientific Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sequent Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sequent Scientific Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sequent Stock Analysis
When running Sequent Scientific's price analysis, check to measure Sequent Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sequent Scientific is operating at the current time. Most of Sequent Scientific's value examination focuses on studying past and present price action to predict the probability of Sequent Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sequent Scientific's price. Additionally, you may evaluate how the addition of Sequent Scientific to your portfolios can decrease your overall portfolio volatility.